Detalhe da pesquisa
1.
CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib.
Cancer Sci
; 112(6): 2314-2324, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792119
2.
Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells.
Blood
; 131(16): 1833-1845, 2018 04 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29371181
3.
Dual inhibition of enhancer of zeste homolog 1/2 overactivates WNT signaling to deplete cancer stem cells in multiple myeloma.
Cancer Sci
; 110(1): 194-208, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30343511
4.
Essential role of PU.1 in maintenance of mixed lineage leukemia-associated leukemic stem cells.
Cancer Sci
; 106(3): 227-36, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25529853
5.
Nuclear export signal within CALM is necessary for CALM-AF10-induced leukemia.
Cancer Sci
; 105(3): 315-23, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24397609
6.
Roles of AML1/RUNX1 in T-cell malignancy induced by loss of p53.
Cancer Sci
; 104(8): 1033-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23679839
7.
Dual inhibition of EZH1/2 induces cell cycle arrest of B cell acute lymphoblastic leukemia cells through upregulation of CDKN1C and TP53INP1.
Int J Hematol
; 117(1): 78-89, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36280659
8.
Genetic and chemical targeting of the ATPase complex TIP48 and 49 impairs acute myeloid leukemia.
Leukemia
; 37(9): 1812-1829, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491463
9.
MOZ is critical for the development of MOZ/MLL fusion-induced leukemia through regulation of Hoxa9/Meis1 expression.
Blood Adv
; 6(19): 5527-5537, 2022 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35947126
10.
Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors.
Mol Ther Oncolytics
; 27: 14-25, 2022 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36212776
11.
Tip60 activates Hoxa9 and Meis1 expression through acetylation of H2A.Z, promoting MLL-AF10 and MLL-ENL acute myeloid leukemia.
Leukemia
; 35(10): 2840-2853, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33967269
12.
A Potent Blood-Brain Barrier-Permeable Mutant IDH1 Inhibitor Suppresses the Growth of Glioblastoma with IDH1 Mutation in a Patient-Derived Orthotopic Xenograft Model.
Mol Cancer Ther
; 19(2): 375-383, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727689
13.
Sirt1 physically interacts with Tip60 and negatively regulates Tip60-mediated acetylation of H2AX.
Biochem Biophys Res Commun
; 390(4): 1355-60, 2009 Dec 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19895790
14.
Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.
Oncogene
; 38(42): 6835-6849, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31406254
15.
Mllt10 knockout mouse model reveals critical role of Af10-dependent H3K79 methylation in midfacial development.
Sci Rep
; 7(1): 11922, 2017 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-28931923
16.
EPC1/TIP60-Mediated Histone Acetylation Facilitates Spermiogenesis in Mice.
Mol Cell Biol
; 37(19)2017 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28694333
17.
Effect of the DNA topoisomerase II inhibitor VP-16 on illegitimate recombination in yeast chromosomes.
Gene
; 291(1-2): 251-7, 2002 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-12095698
18.
Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
Int J Hematol
; 99(1): 21-31, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24258712